Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 55.0B | 72.9B | 61.8B | 59.8B |
| Cost of revenue | 28.5B | 40.2B | 33.6B | 34.0B |
| Gross profit | 26.5B | 32.7B | 28.2B | 25.8B |
| Operating expense | ||||
| Research & development | 12.0B | 13.9B | 13.1B | 14.9B |
| Selling general and admin | 8.6B | 10.5B | 9.4B | 10.5B |
| Other operating expenses | -8M | -1.4B | -4M | — |
| Operating income | 5.9B | 9.7B | 5.7B | 415M |
| Non operating interest income | ||||
| Income | 619M | -170M | 724M | 742M |
| Expense | 805M | 435M | 991M | 1.0B |
| Other income expense | 151M | -1.6B | -129M | -14.0B |
| Pretax income | 5.9B | 7.6B | 5.3B | -13.9B |
| Tax provision | 1.6B | 2.7B | 1.4B | -2.9B |
| Net income | 4.2B | 4.9B | 3.9B | -11.0B |
| Basic EPS | 1.3 | 1.4 | 1.1 | -3.3 |
| Diluted EPS | 1.2 | 1.4 | 1.1 | -3.3 |
| Basic average shares | 36.3B | 36.3B | 36.3B | 36.2B |
| Diluted average shares | 36.3B | 36.3B | 36.3B | 36.3B |
| EBITDA | 9.3B | 9.3B | 8.7B | 19.2B |
| Net income from continuing op. | 4.2B | 4.9B | 3.9B | -11.0B |
| Minority interests | -68M | -100M | -67M | -133M |
| Preferred stock dividends | — | — | — | — |